RxPG News Feed for RxPG News

Medical Research Health Special Topics World
 Asian Health
 Food & Nutrition
 Men's Health
 Mental Health
 Occupational Health
 Public Health
 Sleep Hygiene
 Women's Health
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 World Healthcare
   Latest Research
 Alternative Medicine
 Clinical Trials
 Infectious Diseases
 Sports Medicine
   Medical News
 Awards & Prizes
   Special Topics
 Odd Medical News

Last Updated: Oct 11, 2012 - 10:22:56 PM
Research Article
Radiology Channel

subscribe to Radiology newsletter
Latest Research : Radiology

   EMAIL   |   PRINT
First breast PET/CT scanner to visualize suspected cancerous lesions in 3-D.

Sep 4, 2009 - 11:36:11 PM , Reviewed by: Dr. Sanjukta Acharya

[RxPG] An innovative collaboration among UC Davis engineers, physicists and radiologists has resulted in the first-ever fully 3-D breast imaging technique that uses both high-resolution PET and CT scanning.

After years of work to build the dedicated breast PET/CT scanner, the team of scientists has shown that use of the technology on an uncompressed breast can accurately visualize suspected cancerous lesions in three dimensions.

Researchers say their findings, published in the September issue of the Journal of Nuclear Medicine, boost efforts to personalize breast cancer treatment for patients.

“People have been talking about individualized chemotherapy for breast cancer, and this could be the technology that makes such a paradigm fly,” said Ramsey Badawi, a UC Davis physicist and co-author of the study.

Badawi said breast PET/CT would not replace mammography for regular breast cancer screening, but could be used, for example, to determine whether and which chemotherapy would be beneficial before surgical removal of the tumor. It also could be used to locate small tumors to improve staging and aid in surgery planning.

In developing the system, Badawi recognized the potential benefits of PET (positron emission tomography) combined with CT (computed tomography). PET scans measure physiological functions, help monitor how well drugs are working and distinguish benign from malignant tumors. CT scans provide information about the body’s structure. The combined technologies can result in much better images to help doctors make treatment decisions.

The problem was that the combined technologies are only available on full-body PET/CT scanners, which can’t easily pinpoint breast tumors smaller than one-half inch. A new approach would be needed to image small, early-stage tumors.

Badawi joined forces with UC Davis radiology physicist John Boone, who built the first dedicated breast CT scanner, and with Simon Cherry, director of the UC Davis Center for Molecular and Genomic Imaging, who built the first PET machine with enough resolution to accurately image tumors in mice. Badawi mounted a PET scanner onto Boone’s breast CT scanner to capture the dual data. The team was also assisted by UC Davis biomedical engineer Jinyi Qi, who developed advanced techniques for reconstructing the images.

A breast PET/CT scan takes about 10 minutes per breast. The patient lies on a padded table while the breast hangs down through a circular opening, an approach patients have said is far more comfortable than standard compression-based imaging. The CT images are generated using an X-ray source and detector that are rotated around the breast to produce a 3-D map of the breast structure. The PET scan is done next, using a pair of gamma ray detectors that rotate around the breast to produce a second, 3-D map of breast metabolism.

The combination of the two maps shows the precise location of cancer as “hot spots.” In their study of four patients, Badawi and his colleagues found that the scans produced high-resolution 3-D images that accurately showed the size, extent and location of biopsy-confirmed breast cancer.

Badawi said more clinical trials on the device are needed before it can be moved into commercial development. One trial will use the system to monitor women who will undergo chemotherapy prior to surgery to determine if PET/CT can accurately predict tumor response.

Publication: September issue of the Journal of Nuclear Medicine

Funding information and declaration of competing interests: Project funding for the breast PET/CT came from the Komen Foundation, the California Breast Cancer Research Program, the American Cancer Society and the National Institutes of Health.

Advertise in this space for $10 per month. Contact us today.

Related Radiology News
First breast PET/CT scanner to visualize suspected cancerous lesions in 3-D.
Drug eluting stents may save limbs
Combining patient photos with imaging improves diagnosis
Ultrasound Imaging Improved by New Computer Model
Computer model improves ultrasound image
Indian American develops tool to image tumours
Injectable Microfoam for Varicose Veins safe in Phase II trial
Newer Nonionic Contrast Agents Safe for Children
Electromagnetic breast imaging techniques offer high contrast and ability to distinguish between healthy breast tissue and abnormal tissue
Percutaneous radiofrequency ablation of liver tumors prove safe and effective

Subscribe to Radiology Newsletter

Enter your email address:

 About Dr. Sanjukta Acharya
This news story has been reviewed by Dr. Sanjukta Acharya before its publication on RxPG News website. Dr. Sanjukta Acharya, MBBS MRCP is the chief editor for RxPG News website. She oversees all the medical news submissions and manages the medicine section of the website. She has a special interest in nephrology. She can be reached for corrections and feedback at [email protected]
RxPG News is committed to promotion and implementation of Evidence Based Medical Journalism in all channels of mass media including internet.
 Additional information about the news article
About the UC Davis Department of Biomedical Engineering
The Department of Biomedical Engineering at UC Davis is actively contributing to new approaches to visualizing biological tissues. The results of research in medical imaging provide better diagnostic tools in clinical settings and improve the development of drugs and other therapies. Faculty and graduate students are involved in the development and application of new instruments and techniques in magnetic resonance imaging, ultrasound, positron emission tomography, computed tomography and optical imaging.

About UC Davis Cancer Center
UC Davis Cancer Center is the only National Cancer Institute-designated center serving the Central Valley and inland Northern California, a region of more than 6 million people. Its specialists provide compassionate, comprehensive care for more than 9,000 adults and children every year, and offer patients access to more than 150 clinical trials at any given time. Its innovative research program includes more than 280 scientists from UC Davis Health System in Sacramento, Calif.; the UC Davis campus in Davis, Calif.; and Lawrence Livermore National Laboratory in Livermore, Calif.
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

Contact us

RxPG Online



    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)